Literature DB >> 25659636

Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Pawel Tacik1, Kimberly J Guthrie2, Audrey J Strongosky1, Daniel F Broderick3, Douglas L Riegert-Johnson4, Sha Tang5, Dima El-Khechen5, Alexander S Parker2, Owen A Ross6, Zbigniew K Wszolek7.   

Abstract

Complex neurologic phenotypes are inherently difficult to diagnose. Whole-exome sequencing (WES) is a new tool in the neurologist's diagnostic armamentarium. Whole-exome sequencing can be applied to investigate the "diagnostic odyssey" cases. These cases involve patients with rare diseases that likely have a genetic etiology but have failed to be diagnosed by clinical evaluation and targeted gene testing. We describe such a case, a 22-year-old man who had mild intellectual developmental disability and episodes of jerking ataxic movements that affected his whole body. He underwent numerous multidisciplinary and multicentric evaluations throughout his life that failed to establish a clear diagnosis. Following his visit to Mayo Clinic in Jacksonville, Florida, WES was applied for genetic determination of the unknown disorder in the proband and his biological parents and sister. Additional clinical evaluation, magnetic resonance neuroimaging, electromyography, and electroencephalography of the proband were performed to verify the phenotype after the WES results were available. To our knowledge, this is the first report of the application of WES to facilitate the diagnosis of episodic ataxia type 1. This case illustrates that WES supported by clinical data is a useful and time-saving tool in the evaluation of patients with rare and complex hereditary disorders.
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25659636      PMCID: PMC4354704          DOI: 10.1016/j.mayocp.2015.01.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

1.  Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.

Authors:  L H Eunson; R Rea; S M Zuberi; S Youroukos; C P Panayiotopoulos; R Liguori; P Avoni; R C McWilliam; J B Stephenson; M G Hanna; D M Kullmann; A Spauschus
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

2.  Three novel KCNA1 mutations in episodic ataxia type I families.

Authors:  H Scheffer; E R Brunt; G J Mol; P van der Vlies; R P Stulp; E Verlind; G Mantel; Y N Averyanov; R M Hofstra; C H Buys
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

3.  Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.

Authors:  Brent L Fogel; Hane Lee; Joshua L Deignan; Samuel P Strom; Sibel Kantarci; Xizhe Wang; Fabiola Quintero-Rivera; Eric Vilain; Wayne W Grody; Susan Perlman; Daniel H Geschwind; Stanley F Nelson
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

4.  Hereditary myokymia and periodic ataxia.

Authors:  D H VanDyke; R C Griggs; M J Murphy; M N Goldstein
Journal:  J Neurol Sci       Date:  1975-05       Impact factor: 3.181

Review 5.  Cerebellar ataxias.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Curr Opin Neurol       Date:  2009-08       Impact factor: 5.710

6.  Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.

Authors:  Steven J Shook; Hafsa Mamsa; Joanna C Jen; Robert W Baloh; Lan Zhou
Journal:  Muscle Nerve       Date:  2008-03       Impact factor: 3.217

7.  A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.

Authors:  Michelle K Demos; Vincenzo Macri; Kevin Farrell; Tanya N Nelson; Kristine Chapman; Eric Accili; Linlea Armstrong
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

8.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions.

Authors:  Kelly D Farwell; Layla Shahmirzadi; Dima El-Khechen; Zöe Powis; Elizabeth C Chao; Brigette Tippin Davis; Ruth M Baxter; Wenqi Zeng; Cameron Mroske; Melissa C Parra; Stephanie K Gandomi; Ira Lu; Xiang Li; Hong Lu; Hsiao-Mei Lu; David Salvador; David Ruble; Monica Lao; Soren Fischbach; Jennifer Wen; Shela Lee; Aaron Elliott; Charles L M Dunlop; Sha Tang
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

9.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

Review 10.  Episodic ataxia type 1: a neuronal potassium channelopathy.

Authors:  Sanjeev Rajakulendran; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more
  7 in total

1.  Episodic Ataxia Type 1 (K-channelopathy) Manifesting as Paroxysmal Nonkinesogenic Dyskinesia: Expanding the Phenotype.

Authors:  Kallol K Set; Debabrata Ghosh; A H M Huq; Aimee F Luat
Journal:  Mov Disord Clin Pract       Date:  2017-07-31

Review 2.  Defining the Clinical Value of a Genomic Diagnosis in the Era of Next-Generation Sequencing.

Authors:  Natasha T Strande; Jonathan S Berg
Journal:  Annu Rev Genomics Hum Genet       Date:  2016-05-26       Impact factor: 8.929

3.  Variation among Consent Forms for Clinical Whole Exome Sequencing.

Authors:  Sara A Fowler; Carol J Saunders; Mark A Hoffman
Journal:  J Genet Couns       Date:  2017-07-08       Impact factor: 2.537

Review 4.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

Review 5.  New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

Authors:  Maria Cristina D'Adamo; Sonia Hasan; Luca Guglielmi; Ilenio Servettini; Marta Cenciarini; Luigi Catacuzzeno; Fabio Franciolini
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

6.  Toward clinical genomics in everyday medicine: perspectives and recommendations.

Authors:  Susan K Delaney; Michael L Hultner; Howard J Jacob; David H Ledbetter; Jeanette J McCarthy; Michael Ball; Kenneth B Beckman; John W Belmont; Cinnamon S Bloss; Michael F Christman; Andy Cosgrove; Stephen A Damiani; Timothy Danis; Massimo Delledonne; Michael J Dougherty; Joel T Dudley; W Andrew Faucett; Jennifer R Friedman; David H Haase; Tom S Hays; Stu Heilsberg; Jeff Huber; Leah Kaminsky; Nikki Ledbetter; Warren H Lee; Elissa Levin; Ondrej Libiger; Michael Linderman; Richard L Love; David C Magnus; AnneMarie Martland; Susan L McClure; Scott E Megill; Helen Messier; Robert L Nussbaum; Latha Palaniappan; Bradley A Patay; Bradley W Popovich; John Quackenbush; Mark J Savant; Michael M Su; Sharon F Terry; Steven Tucker; William T Wong; Robert C Green
Journal:  Expert Rev Mol Diagn       Date:  2016-02-24       Impact factor: 5.225

Review 7.  Episodic Ataxias: Faux or Real?

Authors:  Paola Giunti; Elide Mantuano; Marina Frontali
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.